Product NDC: | 66215-401 |
Proprietary Name: | Veletri |
Non Proprietary Name: | epoprostenol sodium |
Active Ingredient(s): | 1500000 ng/10mL & nbsp; epoprostenol sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66215-401 |
Labeler Name: | Actelion Pharmaceuticals US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022260 |
Marketing Category: | NDA |
Start Marketing Date: | 20100422 |
Package NDC: | 66215-401-01 |
Package Description: | 1 VIAL in 1 CARTON (66215-401-01) > 10 mL in 1 VIAL |
NDC Code | 66215-401-01 |
Proprietary Name | Veletri |
Package Description | 1 VIAL in 1 CARTON (66215-401-01) > 10 mL in 1 VIAL |
Product NDC | 66215-401 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epoprostenol sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100422 |
Marketing Category Name | NDA |
Labeler Name | Actelion Pharmaceuticals US, Inc. |
Substance Name | EPOPROSTENOL SODIUM |
Strength Number | 1500000 |
Strength Unit | ng/10mL |
Pharmaceutical Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |